日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial

辅助性阿特珠单抗治疗早期三阴性乳腺癌:ALEXANDRA/IMpassion030随机临床试验

Ignatiadis, Michail; Bailey, Andrew; McArthur, Heather; El-Abed, Sarra; de Azambuja, Evandro; Metzger, Otto; Chui, Stephen Y; Dieterich, Max; Perretti, Thomas; Shearer-Kang, Esther; Molinero, Luciana; Steger, Günther G; Jassem, Jacek; Lee, Soo Chin; Higgins, Michaela; Zarba, Jose; Schmidt, Marcus; Gomez, Henry; Guerrero Zotano, Angel; Moscetti, Luca; Chiu, Joanne; Munzone, Elisabetta; Ben-Baruch, Noa Efrat; Bajetta, Emilio; Ohno, Shinji; Im, Seock-Ah; Werutsky, Gustavo; Gal-Yam, Einav Nili; Gonzalez Farre, Xavier; Tseng, Ling-Ming; Jacot, William; Gluz, Oleg; Shao, Zhimin; Shparyk, Yaroslav; Zimina, Anastasia; Winer, Eric; Cameron, David A; Viale, Giuseppe; Saji, Shigehira; Gelber, Richard; Piccart, Martine

Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial

围手术期阿特珠单抗治疗早期三阴性乳腺癌:随机3期IMpassion031试验的最终结果和ctDNA分析

Mittendorf, Elizabeth A; Assaf, Zoe June; Harbeck, Nadia; Zhang, Hong; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L; Ferrario, Cristiano; Punie, Kevin; Qamra, Aditi; Dieterich, Max; Xu, Yun; Liste-Hermoso, Mario; Shearer-Kang, Esther; Molinero, Luciana; Chui, Stephen Y; Barrios, Carlos H

Advancing equitable access to innovation in breast cancer

促进乳腺癌创新成果的公平获取

O'Reilly, Seamus; Luis, Ines Vaz; Adam, Virginie; Razis, Evangelia D; Urruticoechea, Ander; Arahmani, Amal; Carrasco, Eva; Chua, Boon H; Bliss, Judith; Straehle, Carolyn; Goulioti, Theodora; Lindholm, Barbro; Werutsky, Gustavo; Brain, Etienne; Bedard, Philippe L; Curigliano, Giuseppe; Loi, Sherene; Saji, Shigehira; Cameron, David

Adjuvant S-1 plus endocrine therapy for ER-positive, HER2-negative, primary breast cancer: post-POTENT trial prognostic survey

辅助S-1联合内分泌治疗ER阳性、HER2阴性原发性乳腺癌:POTENT试验后预后调查

Takada, Masahiro; Saji, Shigehira; Ueno, Takayuki; Masuda, Norikazu; Ishiguro, Hiroshi; Ishida, Takanori; Saeki, Toshiaki; Imoto, Shigeru; Ohno, Shinji; Iwata, Hiroji; Sugie, Tomoharu; Aogi, Kenjiro; Takayama, Shin; Sato, Nobuaki; Kai, Yuichiro; Kitada, Masahiro; Nakamura, Rikiya; Watanabe, Kenichi; Matsuyama, Yutaka; Toi, Masakazu

Author Correction: Advancing equitable access to innovation in breast cancer

作者更正:推进乳腺癌创新成果的公平获取

O'Reilly, Seamus; Luis, Ines Vaz; Adam, Virginie; Razis, Evangelia D; Urruticoechea, Ander; Arahmani, Amal; Carrasco, Eva; Chua, Boon H; Bliss, Judith; Straehle, Carolyn; Goulioti, Theodora; Lindholm, Barbro; Werutsky, Gustavo; Brain, Etienne; Bedard, Philippe L; Curigliano, Giuseppe; Loi, Sherene; Saji, Shigehira; Cameron, David

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial

转移性乳腺癌原发肿瘤切除联合全身治疗与单纯全身治疗的疗效比较(JCOG1017,PRIM-BC):一项随机临床试验

Shien, Tadahiko; Hara, Fumikata; Aogi, Kenjiro; Yanagida, Yasuhiro; Tsuneizumi, Michiko; Yamamoto, Naohito; Matsumoto, Hiroshi; Suto, Akihiko; Watanabe, Kenichi; Harao, Michiko; Kanbayashi, Chizuko; Itoh, Mitsuya; Kadoya, Takayuki; Anan, Keisei; Maeda, Shigeto; Sasaki, Keita; Ogawa, Gakuto; Saji, Shigehira; Fukuda, Haruhiko; Iwata, Hiroji

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

TROPION-Breast05:一项随机III期研究,比较Dato-DXd联合或不联合度伐利尤单抗与化疗联合帕博利珠单抗治疗PD-L1高表达的局部复发性不可切除或转移性三阴性乳腺癌患者的疗效。

Schmid, Peter; Oliveira, Mafalda; O'Shaughnessy, Joyce; Cristofanilli, Massimo; Graff, Stephanie L; Im, Seock-Ah; Loi, Sherene; Saji, Shigehira; Wang, Shusen; Cescon, David W; Hovey, Tina; Nawrot, Agata; Tse, Karson; Vukovic, Petra; Curigliano, Giuseppe

Merging of the Fukushima Health Management Survey With the National and Local Cancer Registry to Refine the Detection of Thyroid Cancer Cases After the 2011 Fukushima Daiichi Nuclear Power Plant Accident

2011年福岛第一核电站事故后,将福岛健康管理调查与国家和地方癌症登记处的数据合并,以改进甲状腺癌病例的检测。

Kimura-Tsuchiya, Reiko; Nagao, Masanori; Saji, Shigehira; Hayashi, Fumikazu; Ohira, Tetsuya; Shimura, Hiroki; Furuya, Fumihiko; Suzuki, Satoru; Suzuki, Satoshi; Ishikawa, Tetsuo; Yokoya, Susumu; Ohto, Hitoshi; Yasumura, Seiji

The safety and effectiveness of pegfilgrastim to reduce cancer chemotherapy-induced febrile neutropenia in real-world practice in Japan: a post-marketing surveillance study

在日本真实世界临床实践中,培非格司亭降低癌症化疗引起的发热性中性粒细胞减少症的安全性和有效性:一项上市后监测研究

Shibata, Nobuhiro; Kuwazawa, Hiroshi; Yasukawa, Tomoharu; Iwabuchi, Manabu; Saji, Shigehira

Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)

通过移动应用程序和可穿戴设备收集接受帕博西尼联合内分泌治疗或单独内分泌治疗的 HR +/HER2 - 晚期乳腺癌患者的健康相关生活质量和身体活动情况:6 个月纵向研究 (JBCRG-26)

Bando, Hiroko; Ueda, Aya; Terata, Kaori; Doi, Mihoko; Nagai, Shigenori E; Hattori, Masaya; Watanabe, Kenichi; Tamura, Nobuko; Futamura, Manabu; Koizumi, Kei; Niikura, Naoki; Miyaji, Tempei; Muramatsu, Yasuaki; Xu, Linghua; Masuda, Norikazu; Saji, Shigehira